Vitamin D for the management of asthma

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Martineau, Adrian R ^a   Cates, Christopher J ^b   Urashima, Mitsuyoshi ^c   Jensen, Megan ^d   Griffiths, Alex P ^a   Nurmatov, Ulugbek ^e   Sheikh, Aziz ^f   Griffiths, Chris J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; NITRIC OXIDE; PLACEBO; VITAMIN D;

ASTHMA; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; EMERGENCY WARD; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERCALCIURIA; LOW DRUG DOSE; LUNG LAVAGE; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SCORING SYSTEM; SPUTUM ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 84984991165     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011511.pub2     Document Type: Review

References (97)

1. Castro M, King TS, Kunselman SJ, Cabana MD, Denlinger L, Holguin F, et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA 2014;311(20):2083-91.
2. Denlinger LC, King TS, Cardet JC, Craig T, Holguin F, Jackson DJ, et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine 2015;[Epub ahead of print].
3. Denlinger LC, King TS, Cardet JC, Craig TJ, Holguin F, Kraft M, et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology. 2015; Vol. 135:AB109.
4. Jiao J, King TS, McKenzie M, Bacharier LB, Dixon AE, Codispoti CD, et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine. 2015; Vol. 191:A4148.
5. Jiao J, King TS, McKenzie M, Bacharier LB, Dixon AE, Codispoti CD, et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: Secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology 2016;138(2):589-92.
6. Moore WC, King TS, Bleecker ER, Meyers DA, Peters SP, Wenzel SE. Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine. 2015; Vol. 191:A6055.
7. Reid B, Girodet P, Boomer JS, Abdel-Gadir A, Zheng K, Wechsler ME, et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology 2016;138(1):286-9.
8. Jensen M, Mailhot G, Alos N, Rousseau E, White J, Khamessan A, et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine 2015;191:A3360.
9. Jensen ME, Mailhot G, Alos N, Rousseau E, White J, Khamessan A, et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials 2016;17:353. [DOI: 10.1186/s13063-016-1483-1]
10. Lewis E, Fernandez C, Nella A, Hopp R, Gallagher JC, Casale TB. Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma & Immunology 2012;108(4):281-2.
11. Lewis E, Fernandez C, Nella AA, Hopp R, Casale T, Gallagher C. The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology. 2011; Vol. 127:Suppl 1.
12. Majak P, Jerzyiska J, Smejda K, Stelmach I, Timler D, Stelmach W. Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma & Immunology 2012;109(5):329-35.
13. Majak P, Rychlik B, Stelmach I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical & Experimental Allergy 2009;39(12):1830-41.
14. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology 2011;127(5):1294-6.
15. Martineau AR, MacLaughlin BD, Hooper RL, Barnes NC, Jolliffe DA, Choudhury AB, et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax. 2014:A51-2.
16. Martineau AR, MacLaughlin BD, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015;70(5):451-7.
17. Tachimoto H, Mezawa H, Segawa T, Akiyama N, Ida H, Urashima M. Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy 2016;71(7):1001-9.
18. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. The American Journal of Clinical Nutrition 2010;91(5):1255-60.
19. Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics 2014;81(7):650-4.
20. Alansari K, Alattar M, Ibrahim KY, Davidson BL, Elnair MB, Mohamed AN. A randomized trial of vitamin D to reduce pediatric asthma exacerbations. American Journal of Respiratory and Critical Care Medicine. 2015; Vol. 191:A2621.
21. Arshi S, Fallahpour M, Nabavi M, Bemanian MH, Javad-Mousavi SA, Nojomi M, et al. The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthma. Annals of Allergy, Asthma & Immunology 2014;113(4):404-9.
22. Bantz SK, Dy T, Herzog R. Vitamin D deficiency in a young, atopic pediatric population. Journal of Allergy and Clinical Immunology. 2015; Vol. 135 (2 Suppl 1):AB148.
23. Baris S, Kiykim A, Ozen A, Tulunay A, Karakoc-Aydiner E, Barlan IB. Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite. Allergy 2014;69(2):246-53.
24. Safa B, Karakoc-Aydiner E, Cagan H, Kiykim A, Tulunay A, Akkoc T, et al. 25 (OH) vitamin D3 as an adjunct to subcutaneous allergen immunotherapy: Is it effective?. 31st Congress of the European Academy of Allergy and Clinical Immunology; 2012 June 16-20; Geneva. 2012.
25. Bar Yoseph R, Livnat G, Schnapp Z, Hakim F, Dabbah H, Goldbart A. The effect of vitamin D on airway reactivity and inflammation in asthmatic children: a double-blind placebo-controlled trial. Pediatric Pulmonology 2015;50(8):747-53. [DOI: 10.1002/ppul.23076]
26. Bar-Yoseph R, Livnat G, Schnapp Z, Dabbah H, Goldbart A, Bentur LPY. The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children. European Respiratory Society Annual Congress; 2013 Sept 7-11; Barcelona, Spain. 2013; Vol. 42, Suppl 57:1159.
27. Breitenbuecher A, Voit U, Miedinger D, Chhajed P, Krapf R, Leuppi J. Calcitriol-treatment in patients with severe persistent asthma: A randomized, placebo-controlled study. Respiration; International Review of Thoracic Diseases 2014;87(6):523-4.
28. Breitenbuecher A, Voit U, Miedinger D, Leuppi J, Krapf R. Substitution of vitamin D in patients with moderate to severe persistent asthma: A randomized, placebo-controlled pilot study. European Respiratory Journal 2012;40:Suppl 56 4698.
29. Darabi B, Moin M, Pourpak Z. The effect of vitamin D supplementation over asthma outcome. 2nd International Congress of Immunology; 2013 Feb 19-21; Tehran. 2013.
30. De Groot JC, Van Roon ENH, Storm H, Veeger NJ, Bel EHD, Ten Brinke A. The effect of vitamin D on airway inflammation in non-atopic asthma. American Journal of Respiratory and Critical Care Medicine. 2014; Vol. 189:A1390.
31. De Groot JC, van Roon EN, Storm H, Veeger NJ, Zwinderman AH, Hiemstra PS, et al. Vitamin D reduces eosinophilic airway inflammation in non-atopic asthma. Journal of Allergy and Clinical Immunology 2015;135(3):670-5.
32. de Groot JC, van Roon EN, Storm H, Bel EH, ten Brinke A. The effect of a single high dose vitamin D3 on neutrophilic airway inflammation in nonatopic asthma. European Respiratory Journal. 2012; Vol. 40 Suppl 56:P1790.
33. Goldring ST, Griffiths CJ, Martineau AR, Robinson S, Yu C, Poulton S, et al. Prenatal vitamin D supplementation and child respiratory health: a randomised controlled trial. PLoS One 2013;8(6):e66627.
34. Lakatos P, Nagy Z, Kiss L, Horvath C, Takacs I, Foldes J, et al. Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Zeitschrift fur Rheumatologie. 2000; Vol. 59 (Suppl 1):48-52.
35. Litonjua AA, Lange NE, Carey VJ, Brown S, Laranjo N, Harshfield BJ, et al. The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemporary Clinical Trials 2014;38(1):37-50.
36. McDonald CF, Matthews S, Seeman E. A two year double blind placebo controlled prospective study of the effects of calcitriol on bone mineral density (BMD) in patients with asthma. Proceedings of the Thoracic Society of Australia & New Zealand, Annual Scientific Meeting; 2003 April 4-9; Adelaide. 2003:P022.
37. McDonald CF, Zebaze RMD, Seeman E. Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial. Osteoporosis International 2006;17(10):1546-51.
38. Menon B, Nima G, Dogra V, Mittal A, Kaur C, Mittal U. Evaluation of vitamin D in bronchial asthma and the effect of vitamin D supplementation on asthma severity and control: A randomised control trial. European Respiratory Journal. 2014; Vol. 44 Suppl 58:P4049.
39. Chambers ES, Nanzer AM, Pfeffer PE, Richards DF, Martineau AR, Griffiths CJ, et al. Calcitriol restores glucocorticoid responsiveness in steroid resistant asthmatics through reduction of IL-17A. Immunology. 2014; Vol. 143:50.
40. Chambers ES, Nanzer AM, Pfeffer PE, Richards DF, Timms PM, Martineau AR, et al. Distinct endotypes of steroid-resistant asthma characterized by IL-17A (high) and IFN-gamma (high) immunophenotypes: Potential benefits of calcitriol. Journal of Allergy and Clinical Immunology 2015;136(3):628-37.
41. Chambers ES, Nanzer AM, Richards DF, Freeman A, Ryanna K, Griffiths C, et al. Serum 25(OH)D levels can predict Foxp3+ treg frequency and steroid responsiveness in severe asthmatics. Immunology 2011;135:S1.
42. Nanzer AM, Chambers ES, Ryanna K, Freeman AT, Colligan G, Richards DF, et al. The effects of calcitriol treatment in glucocorticoid-resistant asthma. Journal of Allergy and Clinical Immunology 2014;133(6):1755-7.
43. Price OJ, Hull JH, Howatson G, Robson-Ansley P, Ansley L. Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: A pilot study. Expert Review of Respiratory Medicine 2015;9(3):369-78.
44. Nageswari AD, Rajanandh MG, Priyanka RK, Rajasekhar P. Effect of vitamin D3 on mild to moderate persistent asthmatic patients: A randomized controlled pilot study. Perspectives in Clinical Research 2014;5(4):167-71.
45. Rajanandh MG, Nageswari AD, Prathiksha G. Effectiveness of vitamin D3 in severe persistent asthmatic patients: A double blind, randomized, clinical study. Journal of Pharmacology and Pharmacotherapeutics 2015;6(3):142-6.
46. Schou AJ, Heuck C, Wolthers OD. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?. Pediatric Pulmonology 2003;36(5):399-404.
47. Wolthers OD, Schou AJ, Heuck C. A double blind trial of vitamin-D in children with asthma treated with inhaled budesonide. European Respiratory Society 9th Annual Congress; 1999 Oct 9-13; Madrid. 1999.
48. Thijs W, Janssen K, Verhoosel RM, Papapoulos SE, Le Cessie S, Middeldorp S, et al. Effect of vitamin D treatment on antimicrobial peptides in asthma patients and healthy controls. ERJ 2011;38(55):4888.
49. Torres J, Martinez M, Chavez E, Garcia D, Fabiano F, Hernandez J. Vitamin D levels in peripheral blood in patients with mild to moderate bronchial asthma. European Academy of Allergy and Clinical Immunology and World Allergy Organization World Allergy and Asthma Congress; 2013 June 22-26; Milan Italy. 2013:68.
50. Utz G, Hauck AM. Oral application of calcium and vitamin D2 in allergic bronchial asthma. MMW Munch Med Wochenschr 1976;118(43):1395-8.
51. Worth H, Stammen D, Keck E. Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate. American Journal of Respiratory and Critical Care Medicine 1994;150(2):394-7.
52. Yemelyanov A, Shevelev S, Murzin B, Shubin S. Efficacy and safety of calcium and vitamin D in treatment of steroid osteoporosis in asthmatic patients. European Respiratory Journal 2001;18:S33.
53. Maguire JL, Birken CS, Loeb MB, Mamdani M, Thorpe K, Hoch JS, et al. DO IT Trial: vitamin D outcomes and interventions in toddlers - a TARGet Kids! randomized controlled trial. BMC Pediatrics 2014;8(14):37.
54. NCT01419262 DO IT Trial: Vitamin D outcomes and interventions in toddlers (DO IT). https://clinicaltrials.gov/ct2/show/NCT01419262 (accessed 11 August 2016).
55. NCT01728571 LungVITamin D and OmegA-3 Trial (lungVITAL) (lungVITAL). https://clinicaltrials.gov/ct2/show/NCT01728571 (accessed 11 August 2016).
56. NCT02197702 Vitamin D in preschoolers with viral-induced asthma (DIVA). https://clinicaltrials.gov/ct2/show/NCT02197702 (accessed 11 August 2016).
57. NCT02424552 Effect of vitamin D as add-on therapy for vitamin D insufficient patients with severe asthma (EVITA). https://clinicaltrials.gov/ct2/show/NCT02424552 (accessed 11 August 2016).
58. Hutchinson K, Kerley C, Elnazir B, Couglan D, Greally P, Rochev Y, et al. A randomized, double-blind, placebo-controlled trial of vitamin D for Irish children with asthma: Baseline data. Irish Journal of Medical Science. 2014; Vol. 183 (9 Suppl 1):S443.
59. Kerley C, Greally P, Coughlan D, Elnazir BPY. A randomized, double-blind, placebo-controlled trial of vitamin D3 for Irish children with asthma: Baseline data. European Respiratory Journal. 2014; Vol. 44, Suppl 58:1172.
60. Kerley CP, Hutchinson K, Greally P, Coghlan D, Elnazir B. The effects of vitamin D supplementation on pulmonary function, disease severity and markers of inflammation in childhood asthmatics: A randomized, double-blind, placebo-controlled trial. Irish Journal of Medical Science. 2014; Vol. 183 11 Suppl 1:S522.
61. NCT02428322 Trial of Vitamin D3 Supplementation in Paediatric Asthma (NCHVitDAst). https://clinicaltrials.gov/ct2/show/NCT02428322 (accessed 11 August 2016).
62. Florio G, Rubano A, Patella V. Effect of sublingual specific immunotherapy associated to vitamin D3 and lactobacillus reuteri in asthmatic teens. American Journal of Respiratory and Critical Care Medicine. 2015; Vol. 191:A4269.
63. Patella V, Florio G, Palmieri M. Vitamin D3 associated to lactobacillus reuteri improves effects of allergen immunotherapy in asthmatic children. European Respiratory Society 23rd Annual Congress; 2013 Sep 7-11; Barcelona. 2013.
64. UMIN000004160 A randomized, double blind, comparative study of vitamin D3 versus placebo in small children with asthma to prevent asthma attack. https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_his_list.cgi?recptno=R000004995 (accessed 11 August 2016).
65. Martineau AR, Jolliffe DA, Hooper RL, Khan KS, Griffiths CJ, Camargo CA Jr. Individual patient data meta-analysis of randomised controlled trials of vitamin D supplementation to prevent acute respiratory infection and acute exacerbations of asthma and COPD. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014013953 (accessed 11 August 2016).
66. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. Journal of Allergy and Clinical Immunology 2010;126(1):52-8 e5.
67. Brehm JM, Acosta-Perez E, Klei L, Roeder K, Barmada M, Boutaoui N, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. American Journal of Respiratory and Critical Care Medicine 2012;186(2):140-6.
68. Confino-Cohen R, Brufman I, Goldberg A, Feldman BS. Vitamin D, asthma prevalence and asthma exacerbations: a large adult population-based study. Allergy 2014;69(12):1673-80.
69. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences 2012;109(38):15449-54.
70. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 11 August 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
71. Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015;7(6):4240-70.
72. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. American Journal of Clinical Nutrition 2003;77:204-10.
73. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at www.cochrane-handbook.org.
74. Holick MF. Vitamin D deficiency. The New England Journal of Medicine 2007;357(3):266-81.
75. Hollis BW, Wagner CL. The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. Journal of Clinical Endocrinology and Metabolism 2013;98(12):4619-28.
76. Janssens W, Decramer M, Mathieu C, Korf H. Vitamin D and chronic obstructive pulmonary disease: hype or reality?. The Lancet Respiratory Medicine 2013;1(10):804-12.
77. Johnston NW, Sears MR. Asthma exacerbations 1: epidemiology. Thorax 2006;61(8):722-8.
78. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2(1):75-9.
79. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009;64(6):476-83.
80. Lan N, Luo G, Yang X, Cheng Y, Zhang Y, Wang X, et al. 25-hydroxyvitamin d3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS ONE 2014;9(11):e111599.
81. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease. Annals of Internal Medicine 2012;156:105-14.
82. Luo J, Liu D, Liu C-T. Can vitamin D supplementation in addition to asthma controllers improve clinical outcomes in patients with asthma? A meta-analysis. Medicine (Baltimore) 2015;94(50):e2185.
83. Mann EH, Chambers ES, Pfeffer PE, Hawrylowicz CM. Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma. Annals of the New York Academy of Sciences 2014;1317:57-69.
84. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. Journal of Immunology 2007;178(11):7190-8.
85. Martineau AR. Bolus-dose vitamin D and prevention of childhood pneumonia. The Lancet 2012;379(9824):1373-5.
86. Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. The Lancet Respiratory Medicine 2015;3(2):120-30.
87. Martineau A, Takeda A, Nurmatov U, Sheikh A, Griffiths CJ. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews 2015, Issue 3. [DOI: 10.1002/14651858.CD011511]
88. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):Epub 2009 Jul 21. [DOI: 10.1371/journal.pmed.1000097]
89. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. American Journal of Respiratory and Critical Care Medicine 2009;180(1):59-99.
90. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2015.
91. Riverin BD, Maguire JL, Li P. Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis. PLoS ONE 2015;10(8):e0136841.
92. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. Journal of Clinical Endocrinology and Metabolism 2008;93(8):3015-20.
93. Singh AM, Busse WW. Asthma exacerbations 2: aetiology. Thorax 2006;61(9):809-16.
94. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012;12:204.
95. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Research 2009;29(9):3675-84.
96. Xiao L, Xing C, Yang Z, Xu S, Wang M, Du H, et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. British Journal of Nutrition 2015;114:1026-34.
97. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. Journal of Clinical Investigation 2006;116(1):146-55.